(Q45867858)

17 December 2017

title

Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: implications for gene therapy (English)

1 reference

17 December 2017

inflammatory bowel diseases

0 references

0 references

1 reference

1 reference

Sander van der Marel

1

1 reference

17 December 2017

Elisabeth M Comijn

2

1 reference

17 December 2017

Hein W Verspaget

3

1 reference

17 December 2017

Sander van Deventer

4

1 reference

17 December 2017

Gijs R van den Brink

5

1 reference

17 December 2017

Harald Petry

6

1 reference

17 December 2017

Daniel W Hommes

7

1 reference

17 December 2017

Valerie Ferreira

8

1 reference

17 December 2017

publication date

2 March 2011

1 reference

17 December 2017

Inflammatory Bowel Diseases

published in

1 reference

17 December 2017

volume

17

1 reference

17 December 2017

issue

12

1 reference

17 December 2017

page(s)

2436-2442

1 reference

17 December 2017

Inflammatory bowel disease: cause and immunobiology

cites work

1 reference

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

21 January 2018

1 reference

Celiac disease: a model autoimmune disease with gene therapy applications

21 January 2018

1 reference

Gene transfer approaches for the treatment of inflammatory bowel disease

21 January 2018

1 reference

Progress and prospects: gene therapy clinical trials (part 2).

21 January 2018

1 reference

Progress and prospects: gene therapy clinical trials (part 1).

21 January 2018

1 reference

Peroral gene therapy of lactose intolerance using an adeno-associated virus vector

21 January 2018

1 reference

Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5.

21 January 2018

1 reference

Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors

21 January 2018

1 reference

Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

21 January 2018

1 reference

Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors

21 January 2018

1 reference

Impact of preexisting vector immunity on the efficacy of adeno-associated virus-based HIV-1 Gag vaccines.

21 January 2018

1 reference

Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice

21 January 2018

1 reference

Strategies for manufacturing recombinant adeno-associated virus vectors for gene therapy applications exploiting baculovirus technology

21 January 2018

1 reference

Epidemiology of ulcerative colitis in western Norway

21 January 2018

1 reference

Epidemiology of Crohn's disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway

21 January 2018

1 reference

Cytomegalovirus infection in patients with active inflammatory bowel disease

21 January 2018

1 reference

Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis.

21 January 2018

1 reference

Clinical gene therapy using recombinant adeno-associated virus vectors

21 January 2018

1 reference

Gene therapy: the first two decades and the current state-of-the-art

21 January 2018

1 reference

Prospects for the use of adeno-associated virus as a vector for human gene therapy

21 January 2018

1 reference

Current directions in IBD therapy: what goals are feasible with biological modifiers?

21 January 2018

1 reference

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

21 January 2018

1 reference

Inflammatory bowel disease

21 January 2018

1 reference

Chemokines in the inflammatory bowel diseases

21 January 2018

1 reference

The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.21673

1 reference

17 December 2017

PubMed ID

21370319

1 reference

17 December 2017